Cholic Acid

CHEMBL205596 Phase 4 Đã phê duyệt Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
408.6 g/mol
LogP
3.6
Phase
4

A primary bile acid that facilitates the absorption of dietary fats and fat-soluble vitamins in the small intestine by emulsifying lipid droplets. It is used therapeutically to treat inborn errors of bile acid synthesis, rare metabolic disorders that impair the body's ability to produce bile acids naturally. Oral replacement with cholic acid helps restore normal bile flow and prevents progressive liver damage.

Khối lượng phân tử

408,6000 g/mol

LogP

3,60

TPSA

98,00 Ų

Lipinski RO5

Đạt

Lĩnh vực điều trị

Cơ chế tác dụng

Serves as an essential micronutrient cofactor in various enzymatic reactions and metabolic processes. Supplementation corrects deficiency states and supports normal physiological function.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Cơ chế

Serves as an essential micronutrient cofactor in various enzymatic reactions and metabolic processes. Supplementation corrects deficiency states and supports normal physiological function.

Cấu trúc 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C

InChI

InChI=1S/C24H40O5/c1-13(4-7-21(28)29)16-5-6-17-22-18(12-20(27)24(16,17)3)23(2)9-8-15(25)10-14(23)11-19(22)26/h13-20,22,25-27H,4-12H2,1-3H3,(H,28,29)/t13-,14+,15-,16-,17+,18+,19-,20+,22+,23+,24-/m1/s1

Molecular Formula

C24H40O5

HBD / HBA

4 / 5

Liên kết có thể quay

4

Nguyên tử nặng

29

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Câu hỏi thường gặp

A primary bile acid that facilitates the absorption of dietary fats and fat-soluble vitamins in the small intestine by emulsifying lipid droplets. It is used therapeutically to treat inborn errors of bile acid synthesis, rare metabolic disorders that impair the body's ability to produce bile acids naturally. Oral replacement with cholic acid helps restore normal bile flow and prevents progressive liver damage.

Serves as an essential micronutrient cofactor in various enzymatic reactions and metabolic processes. Supplementation corrects deficiency states and supports normal physiological function.

Yes, Cholic Acid is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL205596. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 221493. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Tuyên bố miễn trách y tế

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.